Valuation Update With 7 Day Price Move • Jun 29
Investor sentiment deteriorates as stock falls 15% After last week's 15% share price decline to US$1.06, the stock trades at a trailing P/E ratio of 18x. Average forward P/E is 12x in the Insurance industry in the US. Total loss to shareholders of 84% over the past three years. Valuation Update With 7 Day Price Move • May 20
Investor sentiment improves as stock rises 20% After last week's 20% share price gain to US$1.80, the stock trades at a trailing P/E ratio of 30.6x. Average forward P/E is 11x in the Insurance industry in the US. Total loss to shareholders of 65% over the past three years. Board Change • May 20
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 4 experienced directors. No highly experienced directors. Independent Director Bin Wei was the last director to join the board, commencing their role in 2020. The following issues are considered to be risks according to the Simply Wall St Risk Model: Insufficient board refreshment. Announcement • Mar 17
Huize Holding Limited to Report Second Half, 2025 Results on Mar 27, 2026 Huize Holding Limited announced that they will report second half, 2025 results on Mar 27, 2026 Announcement • Nov 27
Huize Holding Limited, Annual General Meeting, Dec 17, 2025 Huize Holding Limited, Annual General Meeting, Dec 17, 2025, at 10:00 China Standard Time. Location: suite 3904-3905, tower 6, the gateway, harbour city, tsim sha tsui, hong kong China Announcement • Oct 02
Huize Holding Limited Announces Resignation of Mr. Aaron Xiaolei Hou as an Independent Director from the Board of Directors and as A Member of Each of the Nominating and Corporate Governance Committee, the Audit Committee and the Compensation Committee of the Board, Effective September 30, 2025 Huize Holding Limited announced that Mr. Aaron Xiaolei Hou has tendered his resignation from his position as an independent director from the board of directors (the “Board”) and as a member of each of the nominating and corporate governance committee, the audit committee and the compensation committee of the Board, effective September 30, 2025, due to personal reasons. Mr. Hou's resignation did not result from any disagreement with the Company. The Board has resolved to appoint Mr. Cunjun Ma as the chairperson of the nominating and corporate governance committee of the Board, replacing Mr. Hou’s role. Announcement • Sep 02
Huize Holding Limited to Report Q2, 2025 Results on Sep 12, 2025 Huize Holding Limited announced that they will report Q2, 2025 results Pre-Market on Sep 12, 2025 Announcement • May 23
Huize Holding Limited to Report Q1, 2025 Results on Jun 06, 2025 Huize Holding Limited announced that they will report Q1, 2025 results Pre-Market on Jun 06, 2025 Announcement • Mar 10
Huize Holding Limited to Report Q4, 2024 Results on Mar 24, 2025 Huize Holding Limited announced that they will report Q4, 2024 results Pre-Market on Mar 24, 2025 Announcement • Jan 16
Huize Launches Customized Mid-Tier Medical Insurance Product “PrimeMed” in Partnership with CCIC and MSH CHINA Huize Holding Limited announced the launch of “PrimeMed”, a customized mid-tier medical insurance product, in collaboration with China Continent Property & Casualty Insurance Co. Ltd. (CCIC) and MSH CHINA Enterprise Services Co. Ltd. (MSH CHINA). Designed to provide scarce, high-cost medical resources such as specialized and international departments in public hospitals and designated private medical institutions, this new solution addresses the need for flexible and affordable insurance coverage. “PrimeMed”’s key features include: Flexible deductibles: three plan options are offered, including zero or low shared deductibles, making inpatient services across different medical institutions more accessible while streamlining enrollment and claims processing. Children’s coverage: allows parents to insure children under 18, expanding protection options for the family. Relative deductible scheme: enables compensation from other sources (such as public health insurance) to offset deductibles, improving the accessibility of benefits. Affordable premiums: annual premiums start from RMB958 for the primary age group, with options to add accident outpatient emergency coverage and receive family package discounts. Announcement • Nov 29
Huize Holding Limited to Report Q3, 2024 Results on Dec 10, 2024 Huize Holding Limited announced that they will report Q3, 2024 results Pre-Market on Dec 10, 2024 Announcement • Nov 01
Huize Holding Limited, Annual General Meeting, Nov 29, 2024 Huize Holding Limited, Annual General Meeting, Nov 29, 2024, at 10:00 China Standard Time. Location: 3904-3905, tower 6, the gateway, harbour city, tsim sha tsui hong kong, China Announcement • Sep 17
Huize Holding Limited to Report Q2, 2024 Results on Sep 25, 2024 Huize Holding Limited announced that they will report Q2, 2024 results Pre-Market on Sep 25, 2024 Announcement • Jun 22
Huize Holding Limited (NasdaqGM:HUIZ) agreed to acquire an unknown minority stake in Global Care Consulting Joint Stock Company from VinaCapital Ventures. Huize Holding Limited (NasdaqGM:HUIZ) agreed to acquire an unknown minority stake in Global Care Consulting Joint Stock Company from VinaCapital Ventures on June 20, 2024. Pursuant to purchase of existing shares and subscription of new shares, VinaCapital Ventures will receive partial consideration of newly issued class A common shares of Huize Holding Limited out of which 50% will be subject to a one-year lock-up period. Announcement • May 18
Huize Holding Limited to Report Q1, 2024 Results on May 23, 2024 Huize Holding Limited announced that they will report Q1, 2024 results After-Market on May 23, 2024 Announcement • Apr 20
Huize Holding Limited Partners with PICC Life Insurance Company Limited to Launch "I Wu You - Low-Threshold Edition" - A Customized Critical Illness Insurance Product Huize Holding Limited announced that it has partnered with PICC Life Insurance Company Limited to launch "i Wu You - Low-Threshold Edition", the latest customized critical illness insurance product in the "i Wu You" series that offers a personalized solution with a relaxed health declaration process to customers. 'i Wu You - Low- Threshold Edition' differentiates itself with three key product offerings: i) flexible coverage for 28 severe and three mild illnesses, with a maximum of one claim for severe illnesses and three claims for mild illnesses and an option of lifetime coverage or up to age 70; ii) a relaxed health declaration process that is open to customers with a history of pre-existing conditions, hospitalization, and premium loading; and iii) a low eligibility threshold open to customers aged 30 to 65. The product also offers customers additional value-added services including multi-disciplinary consultation. Announcement • Apr 17
Huize Holding Limited Partners with Aviva-COFCO Life Insurance Co., Ltd. to Launch Fu Man Jia, a Customized Participating Whole Life Insurance Product Huize Holding Limited announced that it has partnered with Aviva-COFCO Life Insurance Co. Ltd. to launch “Fu Man Jia”, a customized participating whole life insurance product. Fu Man Jia” stands out with three key features: i) stable value growth with long-term potential returns: a guaranteed return on a compound basis of 2.5% with additional non-guaranteed annual dividend; ii) low threshold with high dividend flexibility: policy available to customers from 30 days after birth to 70 years old, with options in receiving dividend payout, including cash payment, dividends on deposit, premium reduction, or purchasing paid-up additional insurance; and iii) enhanced flexibility with premium payment terms of single upfront payment or annual payments ranging from 3 years to 15 years. Announcement • Apr 16
Huize Partners with Ruihua Health Assurance Corporation to Launch "Darwin Critical Care No.9" - A Customized Critical Illness Insurance Product Huize Holding Limited announced that it has partnered with Ruihua Health Assurance Corporation to launch “Darwin Critical Care No.9”, the latest customized critical illness insurance product in the “Darwin Critical Care” series, which was first launched in 2018. Reported Earnings • Mar 24
Full year 2023 earnings released: EPS: CN¥1.40 (vs CN¥0.61 loss in FY 2022) Full year 2023 results: EPS: CN¥1.40 (up from CN¥0.61 loss in FY 2022). Revenue: CN¥1.20b (up 3.3% from FY 2022). Net income: CN¥70.2m (up CN¥101.4m from FY 2022). Profit margin: 5.9% (up from net loss in FY 2022). The move to profitability was primarily driven by lower expenses. Revenue is forecast to stay flat during the next 2 years compared to a 5.9% growth forecast for the Insurance industry in the US. Over the last 3 years on average, earnings per share has increased by 65% per year but the company’s share price has fallen by 58% per year, which means it is significantly lagging earnings. Announcement • Mar 22
Huize Holding Limited (NasdaqGM:HUIZ) announces an Equity Buyback for $5 million worth of its shares. Huize Holding Limited (NasdaqGM:HUIZ) announces a share repurchase program. Under the program, the company will repurchase up to $5 million worth of its class A common shares in the form of American depositary shares. The company expects to fund repurchases made under this program from its cash balance and cash generated from operations. The repurchase program will be valid for 12 months. Announcement • Mar 08
Huize Holding Limited to Report Q4, 2023 Results on Mar 20, 2024 Huize Holding Limited announced that they will report Q4, 2023 results Pre-Market on Mar 20, 2024 Board Change • Mar 02
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. No highly experienced directors. Independent Director Aaron Xiaolei Hou was the last director to join the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Insufficient board refreshment. New Risk • Jan 21
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of American stocks, typically moving 11% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings are forecast to decline by an average of 2.9% per year for the foreseeable future. Minor Risks Share price has been volatile over the past 3 months (11% average weekly change). Market cap is less than US$100m (US$35.8m market cap). Announcement • Dec 15
Huize Holding Limited Partners with PICC Life Insurance Company Limited to Launch "Darwin Critical Care No.8 - Advanced" - Customized Critical Illness Insurance Product Huize Holding Limited announced that it has partnered with PICC Life Insurance Company Limited ("PICC Life") to launch "Darwin Critical Care No.8 - Advanced", the latest customized critical illness insurance product in the "Darwin Critical Care" series, first launched in 2018. 'Darwin Critical Care No. 8 - Advanced' provides extensive coverage for 120 critical, 20 moderate, and 40 mild illnesses, and is distinguished by five key product highlights: i) cost-effectiveness, with a minimum annual premium of RMB 65, providing a maximum of 1 claim for severe illnesses, 3 claims for moderate illnesses, and 5 claims for mild illnesses; ii) rapid protection, with first claim available in as few as 90 days; i) low eligibility threshold, open to a large variety of occupation including electricians, firefighters, sailors, riot police, etc. and a lenient health condition screening for consumers with specified pre-existing conditions; iv) a premium waiver benefit for mild-to-moderate illness; and v) optional benefits including supplemental medical care benefits and benefits of up to 120% of the original sum assured for severe malignant tumors and a premium waiver benefit for critical illness. The product also offers customers value-added services such as unlimited online doctor consultations. Reported Earnings • Nov 23
Third quarter 2023 earnings released: EPS: CN¥0.41 (vs CN¥0.21 loss in 3Q 2022) Third quarter 2023 results: EPS: CN¥0.41 (up from CN¥0.21 loss in 3Q 2022). Revenue: CN¥292.4m (down 17% from 3Q 2022). Net income: CN¥20.2m (up CN¥30.7m from 3Q 2022). Profit margin: 6.9% (up from net loss in 3Q 2022). The move to profitability was driven by lower expenses. Revenue is forecast to grow 16% p.a. on average during the next 2 years, compared to a 6.5% growth forecast for the Insurance industry in the US. Over the last 3 years on average, earnings per share has increased by 36% per year but the company’s share price has fallen by 50% per year, which means it is significantly lagging earnings. Valuation Update With 7 Day Price Move • Nov 18
Investor sentiment improves as stock rises 32% After last week's 32% share price gain to US$1.12, the stock trades at a trailing P/E ratio of 13.9x. Average forward P/E is 11x in the Insurance industry in the US. Total loss to shareholders of 85% over the past three years. Announcement • Nov 06
Huize Holding Limited to Report Q3, 2023 Results on Nov 17, 2023 Huize Holding Limited announced that they will report Q3, 2023 results Pre-Market on Nov 17, 2023 Announcement • Nov 01
Huize Holding Limited, Annual General Meeting, Nov 30, 2023 Huize Holding Limited, Annual General Meeting, Nov 30, 2023, at 10:00 China Standard Time. Location: 76/F, The Center, 99 Queen’s Road Central, Hong Kong Special Administrative Region of the People’s Republic of China Central (Hong Kong) Hong Kong Announcement • Sep 28
Huize Holding Limited Partners with Dingcheng Life to Launch "Xiao Tao Qi No.2" - A Customized Child Critical Illness Insurance Product Huize Holding Limited announced that it has partnered with Dingcheng Life Insurance Company Ltd. (Dingcheng Life) to launch "Xiao Tao Qi No.2", the latest child critical illness insurance product offering in the "Xiao Tao Qi" series, which extends coverage to more illnesses and increases the hospitalization allowances for families seeking protection for their children. “Xiao Tao Qi No.2” provides extensive coverage for 190 severe, moderate and mild illnesses (compared to 183 for “Xiao Tao Qi No.1”). It is also distinguished by three key product highlights: (i) for diseases other than those specified in the policy contract as severe, moderate, and mild illnesses, ICU hospital cash benefits of RMB 1,000 per day (starting from the second day of hospitalization) for up to 90 hospitalization days per policy year and 30% of the insured amount; (ii) hospital cash benefits of RMB 300 per day for up to 60 hospitalization days per policy year and 300 hospitalization days in policy lifetime for accidents or diseases suffered by policy beneficiaries in the aftermath of a diagnosed critical illness; (iii) six optional benefits, including first-time illness care benefits, hospitalization benefits after critical illness, multiple benefits for critical illness, severely extended malignant tumors benefits, family care benefits, and death and total disability benefits. The upgraded product also provides customers with value-added services such as online doctor consultations. Reported Earnings • Aug 17
Second quarter 2023 earnings released: EPS: CN¥0.28 (vs CN¥0.77 loss in 2Q 2022) Second quarter 2023 results: EPS: CN¥0.28 (up from CN¥0.77 loss in 2Q 2022). Revenue: CN¥368.2m (up 48% from 2Q 2022). Net income: CN¥14.1m (up CN¥53.5m from 2Q 2022). Profit margin: 3.8% (up from net loss in 2Q 2022). Revenue is forecast to grow 22% p.a. on average during the next 2 years, compared to a 5.2% growth forecast for the Insurance industry in the US. Over the last 3 years on average, earnings per share has increased by 6% per year but the company’s share price has fallen by 49% per year, which means it is significantly lagging earnings. Breakeven Date Change • Aug 16
Forecast to breakeven in 2023 The 2 analysts covering Huize Holding expect the company to break even for the first time. New consensus forecast suggests the company will make a profit of CN¥44.0m in 2023. Earnings growth of 100% is required to achieve expected profit on schedule. Announcement • Aug 04
Huize Holding Limited to Report Q2, 2023 Results on Aug 15, 2023 Huize Holding Limited announced that they will report Q2, 2023 results Pre-Market on Aug 15, 2023 Reported Earnings • Jun 02
First quarter 2023 earnings released: EPS: CN¥0.35 (vs CN¥0.21 in 1Q 2022) First quarter 2023 results: EPS: CN¥0.35 (up from CN¥0.21 in 1Q 2022). Revenue: CN¥298.9m (flat on 1Q 2022). Net income: CN¥17.9m (up 70% from 1Q 2022). Profit margin: 6.0% (up from 3.5% in 1Q 2022). Revenue is forecast to grow 24% p.a. on average during the next 2 years, compared to a 6.1% growth forecast for the Insurance industry in the US. Over the last 3 years on average, earnings per share has fallen by 3% per year but the company’s share price has fallen by 45% per year, which means it is performing significantly worse than earnings. Announcement • May 20
Huize Holding Limited to Report Q1, 2023 Results on May 30, 2023 Huize Holding Limited announced that they will report Q1, 2023 results at 9:30 AM, US Eastern Standard Time on May 30, 2023 Reported Earnings • Mar 31
Full year 2022 earnings released: CN¥0.61 loss per share (vs CN¥2.11 loss in FY 2021) Full year 2022 results: CN¥0.61 loss per share (improved from CN¥2.11 loss in FY 2021). Revenue: CN¥1.16b (down 48% from FY 2021). Net loss: CN¥31.2m (loss narrowed 71% from FY 2021). Revenue is forecast to grow 39% p.a. on average during the next 2 years, compared to a 5.5% growth forecast for the Insurance industry in the US. Over the last 3 years on average, earnings per share has fallen by 11% per year but the company’s share price has fallen by 42% per year, which means it is performing significantly worse than earnings. Announcement • Dec 15
Huize Regains Compliance with Nasdaq Minimum Bid Price Requirement Huize Holding Limited announced that it has received a notification letter (the "Compliance Notice") from the Listing Qualifications Department of the Nasdaq Stock Market Inc. ("Nasdaq") dated December 13, 2022, informing the Company that it has regained compliance with Nasdaq Listing Rule 5450(a)(1) (the "Minimum Bid Price Requirement"). As previously announced, the Company was notified by Nasdaq on October 12, 2022, that the Company was not in compliance with the Minimum Bid Price Requirement, as the closing bid price of the Company's American depositary shares ("ADSs") was below $1.00 per share for 30 consecutive business days. On December 13, 2022, Nasdaq confirmed in the Compliance Notice that the closing bid price of the Company's ADSs has been at $1.00 per share or greater for 11 consecutive business days from November 28, 2022, through December 12, 2022. According to the Compliance Notice, the Company has regained compliance with Listing Rule 5450(a)(1), and the matter is closed. Breakeven Date Change • Nov 19
Forecast breakeven date pushed back to 2023 The 2 analysts covering Huize Holding previously expected the company to break even in 2022. New consensus forecast suggests losses will reduce by 94% to 2022. The company is expected to make a profit of CN¥21.9m in 2023. Average annual earnings growth of 124% is required to achieve expected profit on schedule. Reported Earnings • Nov 18
Third quarter 2022 earnings released: CN¥0.21 loss per share (vs CN¥1.55 loss in 3Q 2021) Third quarter 2022 results: CN¥0.21 loss per share (improved from CN¥1.55 loss in 3Q 2021). Revenue: CN¥351.8m (up 12% from 3Q 2021). Net loss: CN¥10.5m (loss narrowed 87% from 3Q 2021). Revenue is forecast to grow 29% p.a. on average during the next 3 years, compared to a 5.4% growth forecast for the Insurance industry in the US. Announcement • Nov 12
Huize Holding Limited Provides Earnings Guidance for the Final Quarter of 2022 Huize Holding Limited provided earnings guidance for the final quarter of 2022. Based on the Company’s preliminary assessment of the current market conditions, the Company expects to achieve profitability in the final quarter of 2022. This forecast reflects the Company’s current and preliminary views on the market and operational conditions, which are subject to change as a result of various market uncertainties. Announcement • Nov 04
Huize Holding Limited to Report Q3, 2022 Results on Nov 11, 2022 Huize Holding Limited announced that they will report Q3, 2022 results at 4:00 PM, US Eastern Standard Time on Nov 11, 2022 Announcement • Nov 03
Huize Holding Limited, Annual General Meeting, Dec 01, 2022 Huize Holding Limited, Annual General Meeting, Dec 01, 2022, at 10:00 China Standard Time. Location: 49/F, Building T1, Qianhai Financial Centre Qianhai,Shenzhen-Hong Kong Cooperation Zone, Shenzhen 518000 Shenzhen China Announcement • Oct 22
Huize Partners with Guolian Life Insurance to Launch “Darwin Critical Care No. 7” Huize Holding Limited announced that it has partnered with Guolian Life Insurance Co. Ltd. (“Guolian Life Insurance”) to launch “Darwin Critical Care No. 7”, the latest critical illness insurance product offering in the Darwin Critical Care series, which offers additional benefits for severe/mild malignant tumors and carcinoma in situ, as well as ICU hospitalization benefits covering major diseases outside the list of severe, moderate and mild illnesses. “Darwin Critical Care No.7” policyholders will also be able to take advantage of Huize’s proprietary “Xiao Ma Claim” services. “Darwin Critical Care No. 7” is distinguished by five key product highlights: (i) extensive coverage for 110 critical, 35 moderate, and 40 mild illnesses, with a maximum of 8 claims; (ii) two additional benefits, with one for severe malignant tumors of up to 120% of the insured amount and another for mild malignant tumors and carcinoma in situ of up to 30% of the insured amount; (iii) additional ICU hospitalization benefits of up to 30% of the insured amount for 7 consecutive days of ICU hospitalization caused by major diseases other than those specified in the policy contract, such as shock, cardiac arrest and hypertensive crisis; (iv) cost-effective upgrade options for critical illness protections, such as the optional extension of coverage up to age 70; (v) other optional benefits including death and total disability benefits, family care benefits for critical illnesses before the age of 60, supplemental coverage for major illnesses such as specific cardiovascular diseases, malignant tumors or carcinoma in situ before the age of 60, and additional ICU hospitalization benefits. Reported Earnings • Sep 26
Second quarter 2022 earnings released Second quarter 2022 results: Revenue: CN¥248.2m (up 14% from 2Q 2021). Net loss: CN¥39.4m (loss narrowed 49% from 2Q 2021). Revenue is forecast to grow 27% p.a. on average during the next 3 years, compared to a 5.2% growth forecast for the Insurance industry in the US. Announcement • Sep 10
Huize Holding Limited to Report Q2, 2022 Results on Sep 23, 2022 Huize Holding Limited announced that they will report Q2, 2022 results at 9:30 AM, US Eastern Standard Time on Sep 23, 2022 Reported Earnings • Jun 29
First quarter 2022 earnings released: EPS: CN¥0.21 (vs CN¥0.56 in 1Q 2021) First quarter 2022 results: EPS: CN¥0.21 (down from CN¥0.56 in 1Q 2021). Revenue: CN¥299.5m (down 59% from 1Q 2021). Net income: CN¥10.6m (down 63% from 1Q 2021). Profit margin: 3.5% (down from 3.9% in 1Q 2021). The decrease in margin was driven by lower revenue. Over the next year, revenue is forecast to grow 24% while the industry in the US is not expected to grow. Announcement • Jun 25
Huize Holding Limited Provide Profit Guidance Second Half of 2022 Huize Holding Limited provided profit guidance second half of 2022. Based on the Company's preliminary assessment of the current market conditions, the Company currently expects toachieve quarterly profitability in the second half of 2022. This forecast reflects the Company's current and preliminary views on the market and operational conditions, which are subject to change as a result of various market uncertainties. Announcement • Jun 21
Huize Holding Limited to Report Q1, 2022 Results on Jun 24, 2022 Huize Holding Limited announced that they will report Q1, 2022 results Pre-Market on Jun 24, 2022 Reported Earnings • May 02
Full year 2021 earnings: EPS and revenues exceed analyst expectations Full year 2021 results: CN¥2.11 loss per share (down from CN¥0.45 loss in FY 2020). Revenue: CN¥2.25b (up 84% from FY 2020). Net loss: CN¥107.7m (loss widened 401% from FY 2020). Revenue exceeded analyst estimates by 15%. Earnings per share (EPS) also surpassed analyst estimates by 72%. Over the next year, revenue is forecast to grow 24% while the insurance industry in the US is not expected to grow. Breakeven Date Change • Apr 27
Forecast breakeven date pushed back to 2023 The 2 analysts covering Huize Holding previously expected the company to break even in 2022. New consensus forecast suggests losses will reduce by 56% to 2022. The company is expected to make a profit of CN¥38.8m in 2023. Average annual earnings growth of 99% is required to achieve expected profit on schedule. Announcement • Dec 18
Huize Holding Limited (NasdaqGM:HUIZ) entered into an agreement to acquire Shanghai Senhao Insurance Agency Co., Ltd. for CNY 29.8 million. Huize Holding Limited (NasdaqGM:HUIZ) entered into an agreement to acquire Shanghai Senhao Insurance Agency Co., Ltd. for CNY 29.8 million on December 17, 2021. Transaction is subject to the satisfaction of customary conditions precedent. Transaction is expected to complete in the first quarter of 2022. Reported Earnings • Dec 04
Third quarter 2021 earnings: EPS in line with analyst expectations despite revenue beat Third quarter 2021 results: CN¥1.55 loss per share (down from CN¥0.29 profit in 3Q 2020). Revenue: CN¥315.1m (down 9.6% from 3Q 2020). Net loss: CN¥78.9m (down CN¥93.6m from profit in 3Q 2020). Revenue exceeded analyst estimates by 2.5%. Over the next year, revenue is forecast to grow 55% compared to a 1.0% decline forecast for the industry in the US. Announcement • Dec 03
Huize Holding Limited Provides Earnings Outlook for the Full Year of 2021 Huize Holding Limited provided earnings outlook for the full year of 2021. For the period the company expect total operating revenue to be in the range of RMB 1.9 billion to RMB 2.0 billion, or approximately USD 295 to USD 310 million, an increase of approximately 56% to 64% year-over-year. Breakeven Date Change • Sep 15
Forecast to breakeven in 2021 The 4 analysts covering Huize Holding expect the company to break even for the first time. New consensus forecast suggests the company will make a profit of CN¥23.0m in 2021. Earnings growth of 160% is required to achieve expected profit on schedule. Breakeven Date Change • Sep 12
Forecast to breakeven in 2021 The 4 analysts covering Huize Holding expect the company to break even for the first time. New consensus forecast suggests the company will make a profit of CN¥77.0m in 2021. Earnings growth of 133% is required to achieve expected profit on schedule. Reported Earnings • Sep 12
Second quarter 2021 earnings released: CN¥1.51 loss per share (vs CN¥0.073 loss in 2Q 2020) The company reported a poor second quarter result with increased losses, weaker revenues and weaker control over costs. Second quarter 2021 results: Revenue: CN¥218.6m (down 7.0% from 2Q 2020). Net loss: CN¥77.2m (loss widened CN¥73.5m from 2Q 2020). Valuation Update With 7 Day Price Move • Sep 10
Investor sentiment deteriorated over the past week After last week's 20% share price decline to US$2.38, the stock trades at a forward P/E ratio of 6x. Average forward P/E is 12x in the Insurance industry in the US. Total loss to shareholders of 72% over the past year. Announcement • Aug 25
Huize Holding Limited entered into a binding memorandum of agreement to acquire an unknown majority stake in Hubei Shengs Life & General Insurance Agency Co., Ltd. Huize Holding Limited entered into a binding memorandum of agreement to acquire an unknown majority stake in Hubei Shengs Life & General Insurance Agency Co., Ltd on August 24, 2021. Huize Holding Limited (NasdaqGM:HUIZ) will enter into definitive agreements with Shengs Life & General and its shareholders in connection with the transaction. Following the completion of the transaction, Shengs Life & General will be accounted for as a consolidated subsidiary of the Huize Holding Limited. Transaction is subject to completion of customary conditions. Huize Holding Limited expects the transaction to completed by the end of 2021 Valuation Update With 7 Day Price Move • Aug 13
Investor sentiment deteriorated over the past week After last week's 17% share price decline to CN¥2.70, the stock trades at a forward P/E ratio of 6x. Average forward P/E is 12x in the Insurance industry in the US. Total loss to shareholders of 69% over the past year. Reported Earnings • May 22
First quarter 2021 earnings released: EPS CN¥0.56 (vs CN¥0.21 loss in 1Q 2020) The company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2021 results: Revenue: CN¥735.0m (up 196% from 1Q 2020). Net income: CN¥28.5m (up CN¥34.0m from 1Q 2020). Profit margin: 3.9% (up from net loss in 1Q 2020). The move to profitability was driven by higher revenue. Announcement • May 19
Huize Holding Limited Provides Earnings Guidance for the Second Quarter of 2021 Huize Holding Limited provided earnings guidance for the second quarter of 2021. The company currently expects total operating revenue for the second quarter of 2021 to be in the range of RMB 230 million to RMB 250 million. This forecast reflects the company’s current and preliminary views on the market and operational conditions, which are subject to change as a result of various market uncertainties, including those related to the ongoing COVID-19 pandemic globally. Reported Earnings • Mar 13
Full year 2020 earnings released The company reported a solid full year result with reduced losses, improved revenues and improved control over expenses. Full year 2020 results: Revenue: CN¥1.22b (up 23% from FY 2019). Net loss: CN¥23.6m (loss narrowed 6.9% from FY 2019). Announcement • Mar 05
Huize Holding Limited to Report Q4, 2020 Results on Mar 10, 2021 Huize Holding Limited announced that they will report Q4, 2020 results Pre-Market on Mar 10, 2021 Is New 90 Day High Low • Feb 11
New 90-day high: US$8.15 The company is up 11% from its price of US$7.37 on 12 November 2020. The American market is up 16% over the last 90 days, indicating the company underperformed over that time. However, its price trend is similar to the Insurance industry, which is also up 11% over the same period. Announcement • Feb 10
Huize Holding Limited Announces Changes to Board of Directors Huize Holding Limited announced the appointment of Mr. Aaron Xiaolei Hou to the company's board of directors, effective on February 12, 2021. Mr. Hou will also serve as a member of the audit committee of the board, a member of the compensation committee of the board, and a member of the nominating and corporate governance committee of the board. Mr. Li Jiang, the Company’s Chief Operating Officer, will step down from his position as a director of the Company, effective from the same date, following which the majority of the company's board will be comprised of independent directors. Mr. Jiang will continue to serve as the Chief Operating Officer of the Company. Mr. Hou has nearly 20 years of risk management and capital markets experience. He founded China Springs Capital Co. Ltd. in October 2016, and currently serves as its Chief Executive Officer and Chief Investment Officer. Announcement • Jan 28
Huize Holding Limited Announces Earnings Guidance for the Fourth Quarter of 2020 Huize Holding Limited announced earnings guidance for the fourth quarter of 2020. Total operating revenue for the fourth quarter of 2020 is expected to be at least RMB 380 million, representing a record quarterly high and a year-over-year growth of 47.1%, exceeding the Company's previous guidance of RMB 330 million to RMB 350 million. Is New 90 Day High Low • Jan 20
New 90-day low: US$6.60 The company is down 10.0% from its price of US$7.33 on 21 October 2020. The American market is up 13% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Insurance industry, which is up 16% over the same period. Is New 90 Day High Low • Dec 24
New 90-day low: US$6.95 The company is down 12% from its price of US$7.93 on 24 September 2020. The American market is up 18% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Insurance industry, which is up 19% over the same period. Reported Earnings • Nov 22
Third quarter 2020 earnings released: EPS CN¥0.29 The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2020 results: Revenue: CN¥348.5m (up 23% from 3Q 2019). Net income: CN¥14.7m (up CN¥14.4m from 3Q 2019). Profit margin: 4.2% (up from 0.1% in 3Q 2019). The increase in margin was driven by higher revenue. Announcement • Nov 10
Huize Holding Limited to Report Q3, 2020 Results on Nov 19, 2020 Huize Holding Limited announced that they will report Q3, 2020 results at 9:00 AM, China Standard Time on Nov 19, 2020 Announcement • Nov 03
Huize Holding Limited, Annual General Meeting, Dec 10, 2020 Huize Holding Limited, Annual General Meeting, Dec 10, 2020, at 10:00 China Standard Time. Location: 5/F, Building 3-4, Shenzhen Animation Park, Yuehai Road Nanhai Avenue, Nanshan District Shenzhen China Agenda: To discuss Company affairs with management team. Is New 90 Day High Low • Oct 30
New 90-day low: US$7.19 The company is down 20% from its price of US$9.00 on 31 July 2020. The American market is up 3.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Insurance industry, which is down 3.0% over the same period. Is New 90 Day High Low • Oct 10
New 90-day low: US$7.88 The company is down 17% from its price of US$9.50 on 10 July 2020. The American market is up 10.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Insurance industry, which is up 7.0% over the same period. Announcement • Aug 13
Huize Holding Limited to Report Q2, 2020 Results on Aug 20, 2020 Huize Holding Limited announced that they will report Q2, 2020 results at 9:00 AM, China Standard Time on Aug 20, 2020 
